WE CAN'T HARVEST CURES
WHEN CLINICAL RESEARCH IS DONE IN SILOS,
Learn CDISC from CDISC
2017 Europe Interchange
24 - 28 April 2017
London, England
2017 CDISC Japan Interchange
13-15 June 2017
Tokyo, Japan
Austin, Texas
2017 CDISC International Interchange
13-17 November 2017
CDISC Standards Required for Regulatory Submissions to FDA (U.S.) and PMDA (Japan)
Are You Ready?
Tickets Available

Opportunities

Industry Job Board

Chiltern International Ltd.
King of Prussia, Pennsylvania, United States
Amgen
Thousand Oaks, California, United States
inVentiv Health Clinical
Princeton, New Jersey, United States

Global Regulatory Requirements

CDISC Standards are now required for regulatory submissions to FDA (U.S.) and PMDA (Japan).

Learn More

Get Involved with CDISC

Become a Member

CDISC Members drive global standards. Join 400+ organizations from around the world that support the CDISC vision and mission.

Volunteer

CDISC relies on the subject matter expertise of thousands of volunteers to create vendor-neutral, platform-independent data standards that enable information system interoperability to improve medical research.

Sponsor

Generate awareness to the important work CDISC is doing by sponsoring a CDISC fundraiser or event.

Donate

Allocate your donation to a disease that has affected a loved one. 100% of your contribution will create data standards that improve clinical research processes to develop new treatments, find breakthroughs and unlock cures.

Save Time and Resources

Implementing CDISC standards can save approximately 60% in time and resources to conduct clinical research. And implementing CDISC standards from the start can save 70-90% of study start-up time.

"CDISC has renewed my hope and my dream of making clinical trials faster and more cost-effective by harnessing the data in the EHR."

Kelley Meyer, MS
NRG Oncology Statistics and Data Management Center, University of Pittsburgh

Smarter Research to Unlock Cures

“Having good industry standards for our clinical data is so important because it creates order among the relative chaos of our clinical trial data. When we start to really do that, we can focus our energies on the really innovative and differentiating aspects of the clinical trials we run and stop reinventing the wheel.”

Jonathan Chainey
Global Head, Data Standards, Roche

80% of all electronic clinical trial submissions to FDA

Currently 80% of all electronic clinical trial submissions to the US FDA are submitted using SDTM.

"It is our honor to join the CDISC family. We studied, used, and benefited from CDISC standards, and it is our responsibility to contribute to CDISC."

CDISC Member